<DOC>
	<DOCNO>NCT00154323</DOCNO>
	<brief_summary>Bipolar disorder psychiatric illness clinical characteristic mixed mania , grandiose delusion , suicidality . This study investigate efficacy safety oxcarbazepine treatment patient bipolar disorder type I II .</brief_summary>
	<brief_title>The Efficacy Safety Oral Oxcarbazepine 300-1200 mg/Day Adjuvant Therapy Treatment Bipolar Disorder I II This Study Not Being Conducted United States .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>History bipolar disorder type I II Other serious medical condition Treatment antiepileptic medication Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Oxcarbazepine , bipolar disorder</keyword>
</DOC>